Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ampio Pharmaceuticals (NY: AMPE )

0.4750 USD UNCHANGED
Streaming Delayed Price Updated: 3:46 PM EST, Jan 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.4750 (13)
Ask (Size) 0.4786 (10)
Prev. Close 0.4750
Today's Range 0.4750 - 0.4750
52wk Range 0.4311 - 2.590
Shares Outstanding 202,129,686
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Interesting AMPE Put And Call Options For December 17th
Investors in Ampio Pharmaceuticals Inc (AMPE) saw new options become available this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Ampio To Test Inhaled COVID-19 Treatment In India
The Drugs Controller General of India (DCGI) of the Central Drugs Standard Control Organization (CDSCO)has approved Phase 2 ... 
Tags Health Care Biotech Small Cap
From Benzinga

Performance

YTD
-22.90%
-22.90%
1 Month
-19.49%
-19.49%
3 Month
-68.75%
-68.75%
6 Month
-64.55%
-64.55%
1 Year
-72.70%
-72.70%

More News

Read More
First Week of AMPE November 19th Options Trading
Tags Stocks
From Market News Video
Noteworthy Wednesday Option Activity: STAA, AMPE, TRTN
Tags Stocks
From Market News Video
Why Ampio Pharmaceuticals Stock Is Trading Higher Today
Tags FDA why it's moving Mike Macaluso
From Benzinga
EXCLUSIVE: Ampio's Ampion Shows Benefit In Late-Stage Knee Osteoarthritis Study
Tags Market News News AMPE
From Benzinga
Ampio To Present At October Scientific Conference Evidence Of Ampion's Role In Treating Lupus Nephritis, COVID-19
Tags News AMPE Market News
From Benzinga
First Week of AMPE September 17th Options Trading
Tags Stocks
From Market News Video
Ampio's Phase 2 Study Of Inhaled Ampion In COVID-19 Patients Gets Underway
From Benzinga
Here's Why Ampio Pharmaceuticals Stock Is Surging Today
Tags Market News AMPE
From Motley Fool
Ampio Stock Jumps On Enrollment Expansion Of Mid-Stage COVID-19 Trial To India With Inhaled Ampion
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.